TCL Archive In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform May 9, 1997
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
